Items where Author is "Malinverni, R."

2015

Rüeger, S. and Bochud, P.-Y. and Dufour, J.-F. and Müllhaupt, B. and Semela, D. and Heim, M. H. and Moradpour, D. and Cerny, A. and Malinverni, R. and Booth, D. R. and Suppiah, V. and George, J. and Argiro, L. and Halfon, P. and Bourlière, M. and Talal, A. H. and Jacobson, I. M. and Patin, E. and Nalpas, B. and Poynard, T. and Pol, S. and Abel, L. and Kutalik, Z. and Negro, F.. (2015) Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut, 64 (10). pp. 1605-1615.

2013

Lange, C. M. and Bibert, S. and Dufour, J. F. and Cellerai, C. and Cerny, A. and Heim, M. H. and Kaiser, L. and Malinverni, R. and Mullhaupt, B. and Negro, F. and Semela, D. and Moradpour, D. and Kutalik, Z. and Bochud, P. Y.. (2013) Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Journal of hepatology, Vol. 59, H. 3. pp. 504-509.

Lange, C. M. and Miki, D. and Ochi, H. and Nischalke, H. D. and Bojunga, J. and Bibert, S. and Morikawa, K. and Gouttenoire, J. and Cerny, A. and Dufour, J. F. and Gorgievski-Hrisoho, M. and Heim, M. H. and Malinverni, R. and Mullhaupt, B. and Negro, F. and Semela, D. and Kutalik, Z. and Muller, T. and Spengler, U. and Berg, T. and Chayama, K. and Moradpour, D. and Bochud, P. Y.. (2013) Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS ONE, Vol. 8, H. 5 , e64053.

2012

Lange, C. M. and Bibert, S. and Kutalik, Z. and Burgisser, P. and Cerny, A. and Dufour, J. F. and Geier, A. and Gerlach, T. J. and Heim, M. H. and Malinverni, R. and Negro, F. and Regenass, S. and Badenhoop, K. and Bojunga, J. and Sarrazin, C. and Zeuzem, S. and Muller, T. and Berg, T. and Bochud, P. Y. and Moradpour, D.. (2012) A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE, Vol. 7, H. 7 , e40159.

Kuske, L. and Mensen, A. and Mullhaupt, B. and Negro, F. and Semela, D. and Moradpour, D. and Male, P. J. and Heim, M. H. and Malinverni, R. and Cerny, A. and Dufour, J. F.. (2012) Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss medical weekly, Vol. 142 , w13651.

Patin, E. and Kutalik, Z. and Guergnon, J. and Bibert, S. and Nalpas, B. and Jouanguy, E. and Munteanu, M. and Bousquet, L. and Argiro, L. and Halfon, P. and Boland, A. and Mullhaupt, B. and Semela, D. and Dufour, J. F. and Heim, M. H. and Moradpour, D. and Cerny, A. and Malinverni, R. and Hirsch, H. and Martinetti, G. and Suppiah, V. and Stewart, G. and Booth, D. R. and George, J. and Casanova, J. L. and Brechot, C. and Rice, C. M. and Talal, A. H. and Jacobson, I. M. and Bourliere, M. and Theodorou, I. and Poynard, T. and Negro, F. and Pol, S. and Bochud, P. Y. and Abel, L.. (2012) Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology, Vol. 143, H. 5 , S. 1244-1252.e12.

Bochud, P. Y. and Bibert, S. and Kutalik, Z. and Patin, E. and Guergnon, J. and Nalpas, B. and Goossens, N. and Kuske, L. and Mullhaupt, B. and Gerlach, T. and Heim, M. H. and Moradpour, D. and Cerny, A. and Malinverni, R. and Regenass, S. and Dollenmaier, G. and Hirsch, H. and Martinetti, G. and Gorgiewski, M. and Bourliere, M. and Poynard, T. and Theodorou, I. and Abel, L. and Pol, S. and Dufour, J. F. and Negro, F.. (2012) IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology, Vol. 55, H. 2. pp. 384-394.

Lange, C. M. and Kutalik, Z. and Morikawa, K. and Bibert, S. and Cerny, A. and Dollenmaier, G. and Dufour, J. F. and Gerlach, T. J. and Heim, M. H. and Malinverni, R. and Mullhaupt, B. and Negro, F. and Moradpour, D. and Bochud, P. Y.. (2012) Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology, Vol. 55, H. 4. pp. 1038-1047.

2010

Sgier, C. and Müllhaupt, B. and Gerlach, T. and Moradpour, D. and Negro, F. and Malé, P. J. and Heim, M. H. and Malinverni, R. and Cerny, A. and Dufour, J.-F.. (2010) Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C. Journal of viral hepatitis, Vol. 17, H. 12. pp. 845-850.

2008

Helbling, B. and Overbeck, K. and Gonvers, J.-J. and Malinverni, R. and Dufour, J.-F. and Borovicka, J. and Heim, M. and Cerny, A. and Negro, F. and Bucher, S. and Rickenbach, M. and Renner, E. L. and Mullhaupt, B.. (2008) Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, Vol. 57, H. 11. pp. 1597-1603.

Ciuffreda, D. and Comte, D. and Cavassini, M. and Giostra, E. and Bühler, L. and Perruchoud, M. and Heim, M. H. and Battegay, M. and Genné, D. and Mulhaupt, B. and Malinverni, R. and Oneta, C. and Bernasconi, E. and Monnat, M. and Cerny, A. and Chuard, C. and Borovicka, J. and Mentha, G. and Pascual, M. and Gonvers, J. J. and Pantaleo, G. and Dutoit, V.. (2008) Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. European Journal of Immunology, Vol. 38, H. 10. pp. 2665-2677.